These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17070018)

  • 1. Inhibitory effects of epinastine on chemokine production and MHC class II/CD54 expression in keratinocytes.
    Kobayashi M; Kabashima K; Tokura Y
    J Dermatol Sci; 2007 Feb; 45(2):144-6. PubMed ID: 17070018
    [No Abstract]   [Full Text] [Related]  

  • 2. Downmodulatory effects of the antihistaminic drug bepotastine on cytokine/chemokine production and CD54 expression in human keratinocytes.
    Kobayashi M; Kabashima K; Nakamura M; Tokura Y
    Skin Pharmacol Physiol; 2009; 22(1):45-8. PubMed ID: 19088500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive activity of epinastine hydrochloride on TARC production from human peripheral blood CD4+ T cells in-vitro.
    Kanai K; Asano K; Hisamitsu T; Suzaki H
    J Pharm Pharmacol; 2005 Aug; 57(8):1027-36. PubMed ID: 16102259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downmodulatory effects of cetirizine and levocetirizine on cytokine/chemokine production and CD54 expression in keratinocytes.
    Kobayashi M; Tokura Y
    J Dermatol; 2011 Jul; 38(7):717-9. PubMed ID: 21352306
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel antiallergic drug epinastine inhibits IL-8 release from human eosinophils.
    Kohyama T; Takizawa H; Akiyama N; Sato M; Kawasaki S; Ito K
    Biochem Biophys Res Commun; 1997 Jan; 230(1):125-8. PubMed ID: 9020026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cetirizine and hydrocortisone differentially regulate ICAM-1 expression and chemokine release in cultured human keratinocytes.
    Albanesi C; Pastore S; Fanales-Belasio E; Girolomoni G
    Clin Exp Allergy; 1998 Jan; 28(1):101-9. PubMed ID: 9537772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effects of epinastine hydrochloride on IL-4 mRNA expression by peripheral blood mononuclear cells.
    Nakagawa T; Kakinuma Y; Akitaya T; Shimada J; Mizushima Y
    Int Arch Allergy Immunol; 1997; 113(1-3):321-2. PubMed ID: 9130564
    [No Abstract]   [Full Text] [Related]  

  • 8. Preferential downmodulation of certain chemokines by fexofenadine in human keratinocytes.
    Kobayashi M; Tokura Y
    J Dermatol Sci; 2005 Apr; 38(1):67-9. PubMed ID: 15795127
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidermal chemokines and modulation by antihistamines, antibiotics and antifungals.
    Tokura Y; Kobayashi M; Kabashima K
    Exp Dermatol; 2008 Feb; 17(2):81-90. PubMed ID: 18034836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epinastine inhibits eosinophil chemotaxis and adhesion molecules in atopic dermatitis.
    Matsukura M; Yajima A; Yamazaki F; Yudate T; Yamada H; Tezuka T
    Skin Pharmacol Appl Skin Physiol; 2003; 16(6):405-10. PubMed ID: 14528065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive activity of epinastine hydrochloride on eosinophil activation in vitro.
    Mochizuki Y; Furuta A; Furuya A; Kanai K; Asano K; Suzaki H
    In Vivo; 2008; 22(1):13-20. PubMed ID: 18396776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratinocytes enriched for epidermal stem cells differ in their response to IFN-gamma from other proliferative keratinocytes.
    Zeitvogel J; Werfel T; Wittmann M
    Exp Dermatol; 2008 Dec; 17(12):998-1003. PubMed ID: 18557928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subpopulation of human basal keratinocytes has a low/negative MHC class I expression.
    Matic M
    Hum Immunol; 2005 Sep; 66(9):962-8. PubMed ID: 16360835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the class II and class I MHC pathways in human THP-1 monocytic cells by interleukin-27.
    Feng XM; Liu N; Yang SG; Hu LY; Chen XL; Fang ZH; Ren Q; Lu SH; Liu B; Han ZC
    Biochem Biophys Res Commun; 2008 Mar; 367(3):553-9. PubMed ID: 18178151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological and clinical profile of epinastine hydrochloride (Alesion Dry Syrup 1%)].
    Ohmura T; Kawasaki T
    Nihon Yakurigaku Zasshi; 2006 Jan; 127(1):37-46. PubMed ID: 16508222
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulatory effects of antihistamines on the responses to staphylococcal enterotoxin B of human monocyte-derived dendritic cells and CD4+ T cells.
    Iida H; Asada H; Yokoi S; Niizeki H; Yasuda Y; Miyagawa S; Kita E
    J Dermatol Sci; 2008 Oct; 52(1):31-8. PubMed ID: 18524543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of epinastine on the antitussive and rewarding effects of dihydrocodeine in mice.
    Kamei J; Morita K; Ohsawa M; Onodera K
    Methods Find Exp Clin Pharmacol; 1999 Dec; 21(10):663-8. PubMed ID: 10702962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a selective octopamine antagonist, epinastine, on pharyngeal pumping in Caenorhabditis elegans.
    Packham R; Walker RJ; Holden-Dye L
    Invert Neurosci; 2010 Nov; 10(1):47-52. PubMed ID: 20967561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism by which epinastine stops an adenosine analog from contracting BDE rat airways.
    Meade CJ
    Am J Respir Crit Care Med; 1998 Feb; 157(2):522-30. PubMed ID: 9476868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of eosinophil survival by epinastine hydrochloride, an H1 receptor antagonist, in vitro.
    Watase F; Watanabe S; Kanai K; Yamada N; Sakaue S; Asano K; Hisamitsu T; Suzaki H
    In Vivo; 2008; 22(6):687-91. PubMed ID: 19180992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.